Amporin Pharmaceuticals

Amporin Pharmaceuticals develops small-molecule drugs that block and eliminate toxic substances causing cell damage in degenerative diseases. Their technology aims to create effective oral treatments for diseases like Alzheimer's, Parkinson's, and type II diabetes by targeting protein misfolding and aggregation. The company focuses initially on Parkinson's and ALS.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: €157K

Date: 25-Jul-2024

Investors: Venture Kick

Markets: Pharmaceuticals, Biotechnology, Healthtech

HQ: Basel, Basel-Stadt, Switzerland

Founded: 2024

Website: https://www.amporin.com/

LinkedIn: https://www.linkedin.com/company/amporin

Twitter:

Instagram: